Mar
01
Posted under
Blog,
Companies,
Daiichi Sankyo,
Diagnostics,
Funding,
GlaxoSmithKline,
Japan,
joint venture,
Medical Devices,
Medical Supply,
Pharmaceuticals,
Startups,
Universities,
vaccines,
Videos by John Carroll
GlaxoSmithKline ($GSK) and Japan's number three pharma company Daiichi Sankyo have created a joint venture to bring new treatments to the Japanese market, according to a report in the Nikkei.
First, the JV plans to sell approved products contributed by each company, with GSK offering up its cervical cancer vaccine, according to a report in Reuters. Then the two plan to work on new products that aren't already available in Japan.
The key focus of the new JV is on vaccines. GSK sold ¥60 billion worth of vaccines in Japan last year, and Daiichi is looking to build up its work in a field that contributed $1.73 billion in revenue back in 2010.
- here's the story from Reuters
Related Articles:
A bright side to Europe's woes: U.S., Japan look better
GSK looks to Japan for new biotech deals
Feb
03
Posted under
Astellas Pharma,
Blog,
Companies,
Diagnostics,
Funding,
Japan,
Medical Devices,
Medical Supply,
Mergers and Acquisitions,
Pharmaceuticals,
Startups,
Universities,
Videos by John Carroll
Japan's biggest pharma players have been roaming the world in recent years in a restless search for new acquisitions. They've been looking for deals to put an extra oomph into their earnings. Now The Wall Street Journal is reviewing the biggest buyers and seeing who scored the juiciest gains, and who harvested bitter losses. Astellas Pharma, which acquired OSI Pharmaceuticals in 2010, comes out on top. Story
Dec
02
Posted under
BD,
BIO Asia,
BIO Events,
Blog,
Business and Investments,
business development,
Companies,
Diagnostics,
Events,
Funding,
Japan,
Medical Devices,
Medical Supply,
One-on-One's,
Partnering,
Pharmaceuticals,
Startups,
Universities,
Videos,
What would George do? by biotechnow@bio.org (Biotechnology Industry Organization)
With BIO’s Fall events behind us, the team here quickly shifted focus to 2012!
On January 31st, the BIO Asia International Conference will commence its ninth year! What’s something new about the conference? It’s moved! Originally, BIO Asia was hosted in Tokyo, but the event has relocated for the first time and will now be held in Osaka, Japan. We’re very excited about being in this city, which is Japan’s third largest, and is well-known for being an economic powerhouse for the country. People are friendly, the culture is rich, and there is a big mix of interesting companies, small and large, who call Osaka their home.
What else is of note in Osaka? Apparently, it’s a big food city, – and not just instant noodles, or ‘Chicken Ramen’, which was actually invented in Osaka. (Brand-New Osaka.) Some popular dishes you’ll find include Battera (バッテラ), a “block type sushi”, Okonomiyaki (お好み焼き), fried cabbage cakes that look like “a pancake, pizza, and omelette” in one, Takoyaki (たこ焼き), and Kushikatsu (串かつ) (WikiTravel.org). The event itself will be at the Ritz-Carlton, which is located in the Nishi-Umeda business and shopping district. Fun fact: Osaka is home to one of the world’s largest aquariums, “with 11,000 tons of water and plenty of sharks
(including a whale shark), dolphins, otters, seals, and other sea creatures.” The largest tank is meant to represent the Pacific Ocean and contains 5,400 tons of water.
Registration for BIO Asia is open, and BIO’s One-on-One Partnering System has officially launched! (If you’ve already registered, you’ll automatically be sent your login.) Questions, comments? Love Osaka? Leave a note in the comments below!
Learn more about Osaka:
